Member Info for Sangijuelas1

Where are you lot seeing this 184. All I can see is 159 close

those poor little hedge funds that were targeted by WSBets were linked to Steve Cohen and his staff whose former firm was caught insider dealing on news regarding leaks about drug trials.

The only time anyone admitted guilt to SEC yet they are still out there

The Nasdaq drop on the chart will have been institutional investors selling. Now it is being bot controlled

For those saying there won't be a cash raise SNG raised £87m to take their phase 3 forward as drug trials are very expensive.

Sells maybe off book by those in the know. Expect capital raise from the shelf registration

If you don't like the posts why don't you filter instead of being abusive. Axe Cap.
You seem very angry

Should have been in 4D when they dropped it 50% on positive phase 2 trial results.

Me buy

MMs can prise them away from my cold dead hands

Anyone who sells I am never speaking to them ever again. Ever.
I would rather give them away to my wife's boyfriends.
I like the share. It's not for sale.

Paper hands top slice cheap share.
Diamond hands slice gold

I bought more. I like the share.
But don't listen to me, I am autistic fool

As Covid-19 so bad in Brazil and trial done there is there any chance their drugs regulator might look at fast tracking it?
What's the word on manufacturing scale up possibilities?

Pushing story that MAB treatments have failed with new variants so their Coronavirus live comments page good a place as any to push out the news.
Anyone on Twitter might want to tweet Christina Pagel

Tend to improve flexibility with capital raises so that they can be done quickly when the share price is high.
Bulk of the paperwork filed with SEC on registration and will last for 3 years unless option to extend taken up.
So if share price went up substantially can do a quick raise that would be less dilutive than if say it was done now.

Still seen to be hard to administer and if there was a less invasive and easier way of dosing...

The original emergency use authorisation was for use in hospitals like what Trump was given by IV.

This is more like a vaccine and is given as a shot. They are not seriously going to get people without symptoms and hook them up to a drip.

If Parsortix can tell which patients will be better suited to using immunotherapy drugs like Merck's Keytruda and which might not respond, that would indeed be massive.

It's an injection not IV

They already had 4.9% on 01/12 according to significant shareholder page on Angle website so not all new investment